Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 376 | 257 | 361 | 267 | 456 |
| Cost of Goods | 210 | 155 | 231 | 152 | 277 |
| Gross Profit | 166 | 103 | 129 | 116 | 179 |
| Operating Expenses | 1,150 | 1,168 | 1,247 | 711 | 1,624 |
| Operating Income | -984 | -1,066 | -1,118 | -596 | -1,445 |
| Interest Expense | 83 | 95 | 14 | 6 | 7 |
| Other Income | 56 | 215 | 101 | 97 | 88 |
| Pre-tax Income | -1,011 | -946 | -1,031 | -505 | -1,364 |
| Net Income Continuous | -1,011 | -946 | -1,031 | -505 | -1,364 |
| Minority Interests | 102 | N/A | N/A | N/A | N/A |
| Net Income | $-908 | $-817 | $-1,031 | $-505 | $-1,364 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-906 | $-826 | $-997 | $-482 | $-1,341 |